Canada markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.7300+0.0600 (+1.63%)
At close: 04:00PM EDT
3.6500 -0.08 (-2.14%)
After hours: 04:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 308.88M
Enterprise Value -266.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.56
Enterprise Value/Revenue 58.97
Enterprise Value/EBITDA 1.63

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 311.55%
S&P500 52-Week Change 323.06%
52 Week High 35.1900
52 Week Low 32.7650
50-Day Moving Average 33.9962
200-Day Moving Average 33.4680

Share Statistics

Avg Vol (3 month) 3406.01k
Avg Vol (10 day) 3214.4k
Shares Outstanding 584.16M
Implied Shares Outstanding 684.16M
Float 863.74M
% Held by Insiders 19.46%
% Held by Institutions 167.56%
Shares Short (Mar 28, 2024) 41.67M
Short Ratio (Mar 28, 2024) 43.77
Short % of Float (Mar 28, 2024) 42.57%
Short % of Shares Outstanding (Mar 28, 2024) 41.98%
Shares Short (prior month Feb 29, 2024) 41.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.89%
Return on Equity (ttm)-22.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -119.59M
Net Income Avi to Common (ttm)-135.96M
Diluted EPS (ttm)-1.6300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)578.11M
Total Cash Per Share (mrq)6.87
Total Debt (mrq)2.4M
Total Debt/Equity (mrq)0.43%
Current Ratio (mrq)18.24
Book Value Per Share (mrq)6.65

Cash Flow Statement

Operating Cash Flow (ttm)-85.39M
Levered Free Cash Flow (ttm)-9.44M